Conclusion
In conclusion, our review highlights the significance of potential drug-drug interactions involving LAI cabotegravir and rilpivirine and frequently used concomitant medications, particularly in sub-Saharan African countries. Awareness is crucial, spanning healthcare providers, PLWH and dispensing outlets, especially where prescription-free medication access exists.